Order Article Reprints

Lin K-C, Ting L-L, Chang C-L, Lu L-S, Lee H-L, Hsu F-C, Chiou J-F, Wang P-Y, Burnouf T, Ho DC-Y, et al. Ex Vivo Expanded Circulating Tumor Cells for Clinical Anti-Cancer Drug Prediction in Patients with Head and Neck Cancer. Cancers. 2021; 13(23):6076. https://doi.org/10.3390/cancers13236076

Lin, Kuan-Chou, Lai-Lei Ting, Chia-Lun Chang, Long-Sheng Lu, Hsin-Lun Lee, Fang-Chi Hsu, Jeng-Fong Chiou, Peng-Yuan Wang, Thierry Burnouf, Dennis Chun-Yu Ho, and et al. 2021. "Ex Vivo Expanded Circulating Tumor Cells for Clinical Anti-Cancer Drug Prediction in Patients with Head and Neck Cancer" Cancers 13, no. 23: 6076. https://doi.org/10.3390/cancers13236076

Lin, K.-C., Ting, L.-L., Chang, C.-L., Lu, L.-S., Lee, H.-L., Hsu, F.-C., Chiou, J.-F., Wang, P.-Y., Burnouf, T., Ho, D. C.-Y., Yang, K.-C., Chen, C.-Y., Chen, C.-H., Wu, C.-Z., & Chen, Y.-J. (2021). Ex Vivo Expanded Circulating Tumor Cells for Clinical Anti-Cancer Drug Prediction in Patients with Head and Neck Cancer. Cancers, 13(23), 6076. https://doi.org/10.3390/cancers13236076